Literature DB >> 33779949

Bioinformatic and integrated analysis identifies an lncRNA-miRNA-mRNA interaction mechanism in gastric adenocarcinoma.

Yong Liao1, Wen Cao2, Kunpeng Zhang1, Yang Zhou1, Xin Xu1, Xiaoling Zhao1, Xu Yang1, Jitao Wang1, Shouwen Zhao1, Shiyu Zhang1, Longfei Yang1, Dengxiang Liu1, Yanpeng Tian3, Weizhong Wu4.   

Abstract

BACKGROUND: lncRNAs-miRNAs-mRNAs networks play an important role in Gastric adenocarcinoma (GA). Identification of these networks provide new insight into the role of these RNAs in gastric cancer.
OBJECTIVES: Biological information databases were screened to characterize and examine the regulatory networks and to further investigate the potential prognostic relationship this regulation has in GA.
METHODS: By mining The Cancer Genome Atlas (TCGA) database, we gathered information on GA-related lncRNAs, miRNAs, and mRNAs. We identified differentially expressed (DE) lncRNAs, miRNAs, and mRNAs using R software. The lncRNA-miRNA-mRNA interaction network was constructed and subsequent survival examination was performed. Representative genes were selected out using The Biological Networks Gene Ontology plug-in tool on Cytoscape. Additional analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) terms were used to screen representative genes for functional enrichment. Reverse transcription quantitative polymerase chain reaction (RT-qPCR) were used to identify the expression of five candidate differential expressed RNAs.
RESULTS: Information of samples from 375 cases of gastric cancer and 32 healthy cases (normal tissues) were downloaded from the TCGA database. A total of 1632 DE-mRNAs, 1008 DE-lncRNAs and 104 DE-miRNAs were identified and screened. Among them, 65 DE-lncRNAs, 10 DE-miRNAs, and 10 DE-mRNAs form lncRNAs-miRNAs-mRNAs regulatory network. Additionally, 10 lncRNAs and 2 mRNAs were associated with the prognosis of GA. Multivariable COX analysis revealed that AC018781.1 and VCAN-AS1 were independent risk factors for GA. GO functional enrichment analysis found DE-mRNA was significantly enriched TERM (P < 0.05). The KEGG signal regulatory network analysis found 11 significantly enrichment networks, the most prevailing was for the AGE-RAGE signaling pathway associated with Diabetic complications. Results of RT-qPCR was consistent with the in silico results.
CONCLUSIONS: The results of the present study represent a view of GA from a analysis of lncRNA, miRNA and mRNA. The network of lncRNA-miRNA-mRNA interactions revealed here may potentially further experimental studies and may help biomarker development for GA.

Entities:  

Keywords:  DE-RNA; Gastric adenocarcinoma; LncRNAs; MRNAs; MiRNAs

Mesh:

Substances:

Year:  2021        PMID: 33779949     DOI: 10.1007/s13258-021-01086-z

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   1.839


  26 in total

1.  Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

Authors:  Hitoshi Ishiguro; Noboru Nakaigawa; Yasuhide Miyoshi; Kiyoshi Fujinami; Yoshinobu Kubota; Hiroji Uemura
Journal:  Prostate       Date:  2005-06-15       Impact factor: 4.104

2.  Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario.

Authors:  Matthew Dixon; Alyson L Mahar; Lucy K Helyer; Jovanka Vasilevska-Ristovska; Calvin Law; Natalie G Coburn
Journal:  Gastric Cancer       Date:  2014-11-25       Impact factor: 7.370

3.  Global cancer statistics.

Authors:  Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal:  CA Cancer J Clin       Date:  2011-02-04       Impact factor: 508.702

4.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

Review 5.  AGE-RAGE system and carcinogenesis.

Authors:  Riichiro Abe; Sho-ichi Yamagishi
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  V domain of RAGE interacts with AGEs on prostate carcinoma cells.

Authors:  Edith Uetz-von Allmen; Michael Koch; Günter Fritz; Daniel F Legler
Journal:  Prostate       Date:  2008-05-15       Impact factor: 4.104

7.  RETRACTED: Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway.

Authors:  Bole Cao; Cuixia Liu; Guifeng Yang
Journal:  Biomed Pharmacother       Date:  2018-08-05       Impact factor: 6.529

8.  A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA.

Authors:  Marcella Cesana; Davide Cacchiarelli; Ivano Legnini; Tiziana Santini; Olga Sthandier; Mauro Chinappi; Anna Tramontano; Irene Bozzoni
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

9.  A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients.

Authors:  Susanne Blank; Sivaramakrishna Rachakonda; Gisela Keller; Wilko Weichert; Florian Lordick; Rupert Langer; Christoph Springfeld; Thomas Bruckner; Karen Becker; Rajiv Kumar; Katja Ott
Journal:  BMC Cancer       Date:  2014-02-03       Impact factor: 4.430

10.  Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer.

Authors:  Kanagaraj Arun; Ganesan Arunkumar; Duraisamy Bennet; Servarayan Murugesan Chandramohan; Avaniyapuram Kannan Murugan; Arasambattu Kannan Munirajan
Journal:  Oncotarget       Date:  2018-04-06
View more
  1 in total

1.  Bioinformatics analysis of potential Key lncRNA-miRNA-mRNA molecules as prognostic markers and important ceRNA axes in gastric cancer.

Authors:  Siqi Tang; Keyong Liao; Yongpeng Shi; Tingting Tang; Beibei Cui; Zunnan Huang
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.